• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

青光眼患者氧化应激的缓解策略。

Strategies to Reduce Oxidative Stress in Glaucoma Patients.

机构信息

Ophthalmic Research Unit Santiago Grisolia/FISABIO, and Cellular and Molecular Research Unit, University of Valencia, Valencia, Spain.

Spanish Net of Ophthalmic Pathology OFTARED, Institute of Health Carlos III, Madrid, Spain.

出版信息

Curr Neuropharmacol. 2018;16(7):903-918. doi: 10.2174/1570159X15666170705101910.

DOI:10.2174/1570159X15666170705101910
PMID:28677495
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC6120109/
Abstract

BACKGROUND

Primary open-angle glaucoma (POAG) is a multifactorial pathology involving a variety of pathogenic mechanisms, including oxidative/nitrosative stress. This latter is the consequence of the imbalance between excessive formation and insufficient protection against reactive oxygen/nitrogen species.

OBJECTIVE

Our main goal is to gather molecular information to better managing pathologic variants that may determine the individual susceptibility to oxidative/nitrosative stress (OS/NS) and POAG.

METHOD

An extensive search of the scientific literature was conducted using PUBMED, the Web of Science, the Cochrane Library, and other references on the topic of POAG and OS/NS from human and animal model studies published between 2010 and 2017. Finally, 152 works containing relevant information that may help understanding the role of antioxidants, essential fatty acids, natural compounds and other similar strategies for counteracting OS/NS in POAG were considered.

RESULTS

A wide variety of studies have proven that antioxidants, among them vitamins B3, C and E, Coenzyme Q10 or melatonin, ω-3/ω-6 fatty acids and other natural compounds (such as coffee, green tea, bear bile, gingko biloba, coleus, tropical fruits, etc.,) may help regulating the intraocular pressure as well as protecting the retinal neurons against OS/NS in POAG.

CONCLUSION

Based on the impact of antioxidants and ω-3/ω-6 fatty acids at the molecular level in the glaucomatous anterior and posterior eye segments, further studies are needed by integrating all issues involved in glaucoma pathogenesis, endogenous and exogenous risk factors and their interactions that will allow us to reach newer effective biotherapies for preventing glaucomatous irreversible blindness.

摘要

背景

原发性开角型青光眼(POAG)是一种涉及多种致病机制的多因素病理学,包括氧化/硝化应激。后者是由于活性氧/氮物种的过度形成和不足的保护之间的失衡引起的。

目的

我们的主要目标是收集分子信息,以更好地管理可能决定个体对氧化/硝化应激(OS/NS)和 POAG 的易感性的病理变异。

方法

使用 PUBMED、Web of Science、Cochrane 图书馆以及其他关于 POAG 和 OS/NS 的人类和动物模型研究的参考文献,广泛搜索科学文献。最后,考虑了 152 篇包含相关信息的研究报告,这些信息可能有助于了解抗氧化剂、必需脂肪酸、天然化合物和其他类似策略在 POAG 中对抗 OS/NS 的作用。

结果

大量研究已经证明,抗氧化剂,包括维生素 B3、C 和 E、辅酶 Q10 或褪黑素、ω-3/ω-6 脂肪酸和其他天然化合物(如咖啡、绿茶、熊胆、银杏叶、 coleus、热带水果等)可能有助于调节眼压并保护视网膜神经元免受 POAG 中的 OS/NS 损伤。

结论

基于抗氧化剂和 ω-3/ω-6 脂肪酸在青光眼前后节的分子水平上的影响,需要进一步研究整合青光眼发病机制、内源性和外源性危险因素及其相互作用的所有问题,这将使我们能够实现预防青光眼不可逆性失明的更新的有效生物疗法。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b16f/6120109/fc84812cd196/CN-16-903_F3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b16f/6120109/5ba0357c4f7c/CN-16-903_F1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b16f/6120109/495099794188/CN-16-903_F2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b16f/6120109/fc84812cd196/CN-16-903_F3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b16f/6120109/5ba0357c4f7c/CN-16-903_F1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b16f/6120109/495099794188/CN-16-903_F2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b16f/6120109/fc84812cd196/CN-16-903_F3.jpg

相似文献

1
Strategies to Reduce Oxidative Stress in Glaucoma Patients.青光眼患者氧化应激的缓解策略。
Curr Neuropharmacol. 2018;16(7):903-918. doi: 10.2174/1570159X15666170705101910.
2
[Antioxidant nutraceuticals for glaucoma].用于青光眼的抗氧化营养保健品
Vestn Oftalmol. 2020;136(4. Vyp. 2):317-323. doi: 10.17116/oftalma2020136042317.
3
A novel perspective on natural therapeutic approaches in glaucoma therapy.青光眼治疗中自然治疗方法的新视角。
Expert Opin Emerg Drugs. 2007 May;12(2):195-8. doi: 10.1517/14728214.12.2.195.
4
Biomarkers and special features of oxidative stress in the anterior segment of the eye linked to lens cataract and the trabecular meshwork injury in primary open-angle glaucoma: challenges of dual combination therapy with N-acetylcarnosine lubricant eye drops and oral formulation of nonhydrolyzed carnosine.眼前段与晶状体白内障和原发性开角型青光眼小梁网损伤相关的氧化应激的生物标志物和特殊特征:用 N-乙酰基肉碱润眼液和未水解肉碱口服制剂进行双重联合治疗的挑战。
Fundam Clin Pharmacol. 2012 Feb;26(1):86-117. doi: 10.1111/j.1472-8206.2011.00969.x. Epub 2011 Aug 24.
5
Senescent phenotype of trabecular meshwork cells displays biomarkers in primary open-angle glaucoma.小梁细胞衰老表型在原发性开角型青光眼中有生物标志物表现。
Curr Mol Med. 2011 Oct;11(7):528-52. doi: 10.2174/156652411800615126.
6
[Oxidative stress in the trabecular meshwork of POAG].[原发性开角型青光眼小梁网中的氧化应激]
Klin Monbl Augenheilkd. 2010 Feb;227(2):99-107. doi: 10.1055/s-0029-1245171. Epub 2010 Feb 12.
7
Nutritional supplementation in the prevention and treatment of glaucoma.营养补充剂在青光眼的预防和治疗中的应用。
Surv Ophthalmol. 2022 Jul-Aug;67(4):1081-1098. doi: 10.1016/j.survophthal.2021.12.001. Epub 2021 Dec 8.
8
The potential value of natural antioxidative treatment in glaucoma.天然抗氧化治疗在青光眼治疗中的潜在价值。
Surv Ophthalmol. 2008 Sep-Oct;53(5):479-505. doi: 10.1016/j.survophthal.2008.06.006.
9
Current trends in targeting the oxidative stress in glaucoma (Review).当前靶向青光眼氧化应激的治疗趋势(综述)。
Eur J Ophthalmol. 2024 Mar;34(2):328-337. doi: 10.1177/11206721231214297. Epub 2023 Nov 17.
10
The role of oxidative stress in glaucoma.氧化应激在青光眼发病机制中的作用。
Mutat Res. 2006 Mar;612(2):105-14. doi: 10.1016/j.mrrev.2005.11.001. Epub 2006 Jan 18.

引用本文的文献

1
Silicone Oil Affects Fibrosis of Human Trabecular Meshwork Cells by Upregulating Ferroptosis Through a ROS/NOX4/Smad3 Axis.硅油通过ROS/NOX4/Smad3轴上调铁死亡来影响人小梁网细胞的纤维化。
Invest Ophthalmol Vis Sci. 2025 Mar 3;66(3):25. doi: 10.1167/iovs.66.3.25.
2
Serum Oxidative Stress-related Biomarkers in Ocular Hypertension and Glaucoma.高眼压症和青光眼患者血清氧化应激相关生物标志物
J Ophthalmic Vis Res. 2024 Dec 31;19(4):433-439. doi: 10.18502/jovr.v19i4.15011. eCollection 2024 Dec.
3
Aqueous Proteomic and Metabolomic Profiles in Low-Energy vs High-Energy Femtosecond Laser-Assisted Cataract Surgery.

本文引用的文献

1
Targeting Oxidative Stress for Treatment of Glaucoma and Optic Neuritis.靶向氧化应激治疗青光眼和视神经炎。
Oxid Med Cell Longev. 2017;2017:2817252. doi: 10.1155/2017/2817252. Epub 2017 Feb 8.
2
Vitamin B modulates mitochondrial vulnerability and prevents glaucoma in aged mice.维生素B调节老年小鼠的线粒体易损性并预防青光眼。
Science. 2017 Feb 17;355(6326):756-760. doi: 10.1126/science.aal0092.
3
Crosstalk between Oxidative and Nitrosative Stress and Arterial Stiffness.氧化应激和硝化应激之间的相互作用与动脉僵硬度。
低能量与高能量飞秒激光辅助白内障手术中的房水蛋白质组学和代谢组学图谱
Invest Ophthalmol Vis Sci. 2025 Jan 2;66(1):10. doi: 10.1167/iovs.66.1.10.
4
A Reduction in Mitophagy Is Associated with Glaucomatous Neurodegeneration in Rodent Models of Glaucoma.线粒体自噬减少与青光眼啮齿动物模型中的青光眼性神经变性有关。
Int J Mol Sci. 2024 Dec 4;25(23):13040. doi: 10.3390/ijms252313040.
5
Innovative gene delivery systems for retinal disease therapy.用于视网膜疾病治疗的创新基因递送系统。
Neural Regen Res. 2026 Feb 1;21(2):542-552. doi: 10.4103/NRR.NRR-D-24-00797. Epub 2024 Dec 7.
6
RTA408 alleviates retinal ganglion cells damage in mouse glaucoma by inhibiting excessive autophagy.RTA408 通过抑制过度自噬缓解小鼠青光眼的视网膜神经节细胞损伤。
PLoS One. 2024 Nov 11;19(11):e0313446. doi: 10.1371/journal.pone.0313446. eCollection 2024.
7
Glaucoma and dietary links: insights from high-salt intake, the Mediterranean diet, and specific nutrients.青光眼与饮食关联:高盐摄入、地中海饮食及特定营养素的相关见解
Front Nutr. 2024 Oct 24;11:1461748. doi: 10.3389/fnut.2024.1461748. eCollection 2024.
8
Glaucoma: Current and New Therapeutic Approaches.青光眼:当前及新的治疗方法
Biomedicines. 2024 Sep 3;12(9):2000. doi: 10.3390/biomedicines12092000.
9
Antioxidant potential of chlorogenic acid in Age-Related eye diseases.绿原酸在年龄相关性眼病中的抗氧化潜力。
Pharmacol Res Perspect. 2024 Feb;12(1):e1162. doi: 10.1002/prp2.1162.
10
Green Tea Catechins as Therapeutic Antioxidants for Glaucoma Treatment.绿茶儿茶素作为青光眼治疗的抗氧化治疗剂
Antioxidants (Basel). 2023 Jun 21;12(7):1320. doi: 10.3390/antiox12071320.
Curr Vasc Pharmacol. 2017;15(5):446-456. doi: 10.2174/1570161115666170201115428.
4
A New Glaucoma Severity Score Combining Structural and Functional Defects.一种结合结构和功能缺陷的新型青光眼严重程度评分
Klin Monbl Augenheilkd. 2017 Apr;234(4):468-473. doi: 10.1055/s-0042-123725. Epub 2017 Jan 31.
5
CRISPR applications in ophthalmologic genome surgery.CRISPR在眼科基因组手术中的应用。
Curr Opin Ophthalmol. 2017 May;28(3):252-259. doi: 10.1097/ICU.0000000000000359.
6
Correction of Monogenic and Common Retinal Disorders with Gene Therapy.基因疗法矫正单基因和常见视网膜疾病
Genes (Basel). 2017 Jan 27;8(2):53. doi: 10.3390/genes8020053.
7
Oxidative DNA damage and reduced expression of DNA repair genes: Role in primary open angle glaucoma (POAG).氧化DNA损伤与DNA修复基因表达降低:在原发性开角型青光眼(POAG)中的作用。
Ophthalmic Genet. 2017 Sep-Oct;38(5):446-450. doi: 10.1080/13816810.2016.1261904. Epub 2017 Jan 27.
8
Protecting retinal ganglion cells.保护视网膜神经节细胞。
Eye (Lond). 2017 Feb;31(2):218-224. doi: 10.1038/eye.2016.299. Epub 2017 Jan 13.
9
An intraocular drug delivery system using targeted nanocarriers attenuates retinal ganglion cell degeneration.一种使用靶向纳米载体的眼内药物递送系统可减轻视网膜神经节细胞变性。
J Control Release. 2017 Feb 10;247:153-166. doi: 10.1016/j.jconrel.2016.12.038. Epub 2017 Jan 4.
10
Rho kinase inhibitors: a patent review (2014 - 2016).Rho 激酶抑制剂:专利研究综述(2014-2016)。
Expert Opin Ther Pat. 2017 Apr;27(4):507-515. doi: 10.1080/13543776.2017.1272579. Epub 2017 Jan 16.